These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 23712870)

  • 1. Expression and functional significance of ezrin in human brain astrocytoma.
    Mao J; Yuan XR; Xu SS; Jiang XC; Zhao XT
    Cell Biochem Biophys; 2013; 67(3):1507-11. PubMed ID: 23712870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and clinical significance of ezrin in non--small-cell lung cancer.
    Zhang XQ; Chen GP; Wu T; Yan JP; Zhou JY
    Clin Lung Cancer; 2012 May; 13(3):196-204. PubMed ID: 22137559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minichromosome maintenance protein 3 elicits a cancer-restricted immune response in patients with brain malignancies and is a strong independent predictor of survival in patients with anaplastic astrocytoma.
    Söling A; Sackewitz M; Volkmar M; Schaarschmidt D; Jacob R; Holzhausen HJ; Rainov NG
    Clin Cancer Res; 2005 Jan; 11(1):249-58. PubMed ID: 15671553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical expression of cycloxygenase-2 in astrocytoma: correlation with angiogenesis, tumor progression and survival.
    El-Sayed M; Taha MM
    Turk Neurosurg; 2011 Jan; 21(1):27-35. PubMed ID: 21294088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
    Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
    Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas.
    Geiger KD; Stoldt P; Schlote W; Derouiche A
    Am J Pathol; 2000 Dec; 157(6):1785-93. PubMed ID: 11106550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between CacyBP/SIP expression and prognosis in astrocytoma.
    Zhao W; Wang C; Wang J; Ge A; Li Y; Li W; Lu Y
    J Clin Neurosci; 2011 Sep; 18(9):1240-4. PubMed ID: 21764585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of sphingosine kinase-1 expression in human astrocytomas progression and overall patient survival.
    Li J; Guan HY; Gong LY; Song LB; Zhang N; Wu J; Yuan J; Zheng YJ; Huang ZS; Li M
    Clin Cancer Res; 2008 Nov; 14(21):6996-7003. PubMed ID: 18980995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor receptor (FGFR) 4 correlated with the malignancy of human astrocytomas.
    Yamada SM; Yamada S; Hayashi Y; Takahashi H; Teramoto A; Matsumoto K
    Neurol Res; 2002 Apr; 24(3):244-8. PubMed ID: 11958417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ALDH1 expression is correlated with pathologic grade and poor clinical outcome in patients with astrocytoma.
    Liu DY; Ren CP; Yuan XR; Zhang LH; Liu J; Liu Q; Yuan J; Yuan D; Jiang XJ
    J Clin Neurosci; 2012 Dec; 19(12):1700-5. PubMed ID: 23084350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cell cycle regulator p27Kip1 is correlated with survival of patients with astrocytoma.
    Mizumatsu S; Tamiya T; Ono Y; Abe T; Matsumoto K; Furuta T; Ohmoto T
    Clin Cancer Res; 1999 Mar; 5(3):551-7. PubMed ID: 10100706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expressions of peroxiredoxin 1, peroxiredoxin 6 and GFAP in human brain astrocytoma and their clinical significance].
    Zhou J; Liu Q; Wang J; Guo X; Song L
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Sep; 32(9):1255-9. PubMed ID: 22985558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation of hTERT expression to maspin and bFGF expression and their significance in glioma].
    Wang DL; Wang YF; Shi GS; Huang H
    Ai Zheng; 2007 Jun; 26(6):601-6. PubMed ID: 17562265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOX4 is overexpressed in diffusely infiltrating astrocytoma and confers poor prognosis.
    Li L; Li Q; Chen X; Xu M; Li X; Nie L; Chen N; Gong J; Mao Q; Zhou Q
    Neuropathology; 2015 Dec; 35(6):510-7. PubMed ID: 26096696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ezrin expression predicts survival in stage IIB osteosarcomas.
    Kim MS; Song WS; Cho WH; Lee SY; Jeon DG
    Clin Orthop Relat Res; 2007 Jun; 459():229-36. PubMed ID: 17353802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of integrin-linked kinase1 overexpression in astrocytoma.
    Li J; Zhang H; Wu J; Guan H; Yuan J; Huang Z; Li M
    Int J Cancer; 2010 Mar; 126(6):1436-44. PubMed ID: 19676046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ezrin expression in tissue microarray of primary and recurrent gliomas.
    Tynninen O; Carpén O; Jääskeläinen J; Paavonen T; Paetau A
    Neuropathol Appl Neurobiol; 2004 Oct; 30(5):472-7. PubMed ID: 15488023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between ezrin protein expression and the prognosis of colorectal adenocarcinoma.
    Lin LJ; Chen LT
    Mol Med Rep; 2013 Jul; 8(1):61-6. PubMed ID: 23708420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer.
    Elzagheid A; Korkeila E; Bendardaf R; Buhmeida A; Heikkilä S; Vaheri A; Syrjänen K; Pyrhönen S; Carpén O
    Hum Pathol; 2008 Dec; 39(12):1737-43. PubMed ID: 18701134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of frizzled 9 in astrocytomas.
    Zhang Z; Schittenhelm J; Guo K; Bühring HJ; Trautmann K; Meyermann R; Schluesener HJ
    Neuropathol Appl Neurobiol; 2006 Dec; 32(6):615-24. PubMed ID: 17083476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.